The nation of Zimbabwe has declined a major American healthcare agreement worth $367m (272 million pounds) spanning five years due to Washington's insistence on sensitive information.
The decision came to light after a government memo from December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the agreement was "lopsided".
A government representative has since explained that the United States was requesting health data for research and commercial purposes while was not willing to guarantee the resulting advantages from any future vaccines.
"We are forced to start the challenging and unfortunate task of winding down our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had donated more than $1.9bn in health funding to Zimbabwe during the past two decades.
A medical body in Zimbabwe has urged continued negotiations to reach a deal acceptable to all parties so the country's vital HIV treatment initiative can continue.
Broader Background
This development comes after a similar situation in Kenya, where a high court halted a related health funding agreement after concerns were filed about the safety of Kenyans' health data.
After resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
The agency had overseen aid for the US government, but Trump argued its spending was "inefficient" and his government was pursuing direct bilateral agreements to boost transparency and accountability.
As per reports, 16 nations in Africa have so far agreed to these new health pacts, representing more than $18.3bn in committed funds.
Details of the Declined Agreement
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this cooperation might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy through American-funded programmes," the Ambassador commented.
However, official spokesman Nick Mangwana said the proposed deal was "unequal".
"The proposal required Zimbabwe to share its biological resources and data indefinitely, without any corresponding promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.
"Put simply, our country would provide the raw materials for scientific discovery with no assurance that the final treatments would be accessible to our people if a future health crisis arise."
National Interest and International Frameworks
He also pointed out that the US's withdrawal from the global health body and its push of bilateral health agreements were upending structures already established through the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to manage future pandemics.
"This system is designed to guarantee that when a nation provides its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to develop them."
The government's concerns over the US deal "must not be interpreted as hostility towards the US," he added.
"We welcome continued discussions with our US partners on how subsequent co-operation could be structured in a manner that respects the independence and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the official position, but urged that talks should continue given that much of the country's HIV programmes depended on foreign aid.
"Where specific concerns exist, such as those involving information security or agreement terms, these can frequently be resolved via technical clarification and mutually agreed protections," the group commented.
The halted deal highlights the complex challenges between receiving crucial international aid and protecting a country's data in an ever more interconnected world.